Kelly Kaita

7.3k total citations
49 papers, 1.2k citations indexed

About

Kelly Kaita is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Kelly Kaita has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Hepatology, 36 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Kelly Kaita's work include Hepatitis C virus research (34 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (19 papers). Kelly Kaita is often cited by papers focused on Hepatitis C virus research (34 papers), Liver Disease Diagnosis and Treatment (31 papers) and Hepatitis B Virus Studies (19 papers). Kelly Kaita collaborates with scholars based in Canada, United States and France. Kelly Kaita's co-authors include Barry Rosser, Gerald Minuk, David Mymin, Nimer Assy, Gerald Y. Minuk, Eric M. Yoshida, Vincent G. Bain, Morris Sherman, Kevork Peltekian and Mel Krajden and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Kelly Kaita

48 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Kaita Canada 19 887 756 180 115 111 49 1.2k
Makoto Oketani Japan 24 1.1k 1.3× 1.2k 1.5× 188 1.0× 280 2.4× 248 2.2× 68 1.9k
Juan Ignacio Arenas Spain 18 637 0.7× 386 0.5× 92 0.5× 223 1.9× 163 1.5× 44 1.2k
Alessandro Perrella Italy 18 560 0.6× 415 0.5× 123 0.7× 133 1.2× 137 1.2× 92 1.2k
Abdel‐Rahman El‐Zayadi Egypt 19 732 0.8× 722 1.0× 54 0.3× 84 0.7× 118 1.1× 36 1.1k
A Andreana Italy 15 1.2k 1.4× 1.0k 1.4× 95 0.5× 128 1.1× 79 0.7× 28 1.6k
Leonardo de Lucca Schiavon Brazil 19 825 0.9× 753 1.0× 54 0.3× 175 1.5× 109 1.0× 99 1.2k
Anuchit Chutaputti Thailand 16 2.2k 2.4× 2.0k 2.6× 125 0.7× 176 1.5× 188 1.7× 30 2.6k
Gerald Minuk Canada 5 2.0k 2.2× 2.0k 2.6× 171 0.9× 67 0.6× 98 0.9× 8 2.3k
Diego Flichman Argentina 18 1.1k 1.3× 600 0.8× 275 1.5× 71 0.6× 391 3.5× 71 1.5k

Countries citing papers authored by Kelly Kaita

Since Specialization
Citations

This map shows the geographic impact of Kelly Kaita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Kaita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Kaita more than expected).

Fields of papers citing papers by Kelly Kaita

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Kaita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Kaita. The network helps show where Kelly Kaita may publish in the future.

Co-authorship network of co-authors of Kelly Kaita

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Kaita. A scholar is included among the top collaborators of Kelly Kaita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Kaita. Kelly Kaita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartlett, Sofia, Ashley Brown, Kelly Kaita, et al.. (2025). Trends in hepatitis C care in Canada's provincial and territorial prisons from 2020 to 2024. PubMed. 8(4). 523–539. 1 indexed citations
2.
Osiowy, Carla, Kelly Kaita, Stephen Wong, et al.. (2020). Spontaneous Flares of Chronic Hepatitis B Virus in Hepatitis Be Antigen Negative Carriers Who Subsequently Clear Hepatitis B Surface Antigen. Digestive Diseases and Sciences. 66(1). 257–262. 1 indexed citations
3.
Buti, Marı́a, David Wong, Edward Gane, et al.. (2019). Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials. ˜The œLancet. Gastroenterology & hepatology. 4(4). 296–304. 22 indexed citations
4.
Minuk, Gerald Y., et al.. (2017). Concomitant nonalcoholic fatty liver disease does not alter the activity, severity or course of primary biliary cholangitis. Liver International. 38(6). 1110–1116. 12 indexed citations
5.
Osiowy, Carla, et al.. (2010). Molecular characterization of hepatitis B virus and a 9‐year clinical profile in a patient infected with genotype I. Journal of Medical Virology. 82(6). 942–948. 23 indexed citations
6.
Patel, Keyur, Y. Benhamou, Eric M. Yoshida, et al.. (2009). An independent and prospective comparison of two commercial fibrosis marker panels (HCV FibroSURE and FIBROSpect II) during albinterferon alfa‐2b combination therapy for chronic hepatitis C. Journal of Viral Hepatitis. 16(3). 178–186. 36 indexed citations
7.
Dawood, Magdy, et al.. (2009). A mathematical model to study the effect of hepatitis B virus vaccine and antivirus treatment among the Canadian Inuit population. European Journal of Clinical Microbiology & Infectious Diseases. 29(1). 63–72. 18 indexed citations
8.
Rizzetto, Mario, Patrick Marcellin, Pietro Andreoné, et al.. (2008). Tenofovir DF (TDF) showed superior antiviral efficacy to adefovir dipivoxil in a randomized, double-blind, study for the treatment of HBeAg-negative chronic hepatitis B (CHB). Digestive and Liver Disease. 40(5). A19–A19. 3 indexed citations
9.
Bain, Vincent G., Kelly Kaita, Paul Marotta, et al.. (2008). Safety and Antiviral Activity of Albinterferon Alfa-2b Dosed Every Four Weeks in Genotype 2/3 Chronic Hepatitis C Patients. Clinical Gastroenterology and Hepatology. 6(6). 701–706. 16 indexed citations
10.
Sherman, Morris, Eric M. Yoshida, Marc Deschênes, et al.. (2006). Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy. Gut. 55(11). 1631–1638. 65 indexed citations
11.
Kaita, Kelly, Stephen Wong, Eberhard L. Renner, & Gerald Y. Minuk. (2006). Treatment Outcomes in a Centralized Specialty Clinic for Hepatitis C Virus Are Comparable with Those from Clinical Trials. SHILAP Revista de lepidopterología. 20(2). 87–90. 2 indexed citations
12.
Hong, Zhu, Jun Wu, Kelly Kaita, et al.. (2006). Survival Analysis of Liver Transplant Patients in Canada 1997–2002. Transplantation Proceedings. 38(9). 2951–2956. 19 indexed citations
13.
Bain, Vincent G., Eric M. Yoshida, Kelly Kaita, et al.. (2006). Dynamics of interferon-specific gene expression in peripheral blood of interferon alfa-naïve patients with genotype 1 chronic hepatitis C infection treated with albumin-interferon alfa. Hepatology Research. 35(4). 256–262. 8 indexed citations
14.
Minuk, Gerald Y., et al.. (2005). Patient concerns regarding chronic hepatitis C infections. Journal of Viral Hepatitis. 12(1). 51–57. 28 indexed citations
15.
Shen, Hong, Manna Zhang, Kelly Kaita, et al.. (2005). Expression of Fc Fragment Receptors of Immunoglobulin G (Fc?Rs) in Rat Hepatic Stellate Cells. Digestive Diseases and Sciences. 50(1). 181–187. 26 indexed citations
16.
Watt, Kymberly D., Julia Uhanova, Yuewen Gong, et al.. (2004). Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection. Journal of Viral Hepatitis. 11(3). 251–256. 39 indexed citations
17.
Kojima, Hiroshige, Kelly Kaita, Zhenming Xu, et al.. (2003). The absence of up-regulation of telomerase activity during regeneration after partial hepatectomy in hepatitis B virus X gene transgenic mice. Journal of Hepatology. 39(2). 262–268. 17 indexed citations
18.
Kaita, Kelly. (1998). An institutional review of fulminant hepatic failure in an urban Canadian centre. Hepatology Research. 11(2). 115–124. 3 indexed citations
19.
Smith, Pamela J. Olúbùnmi, et al.. (1997). Are community health interventions evaluated appropriately? A review of six journals. Journal of Clinical Epidemiology. 50(2). 137–146. 28 indexed citations
20.
Wong, Stephen, et al.. (1995). The differential effects of three forms of interferon alfa on hepatic regeneration after partial hepatectomy in the rat. Hepatology. 22(3). 883–886. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Makoto Oketani Breakdown of academic impact, for papers by Juan Ignacio Arenas Breakdown of academic impact, for papers by Alessandro Perrella Breakdown of academic impact, for papers by Abdel‐Rahman El‐Zayadi Breakdown of academic impact, for papers by A Andreana Breakdown of academic impact, for papers by Leonardo de Lucca Schiavon Breakdown of academic impact, for papers by Anuchit Chutaputti Breakdown of academic impact, for papers by Gerald Minuk Breakdown of academic impact, for papers by Diego Flichman
Rankless by CCL
2026